FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer

  1. Gaibar, M.
  2. Novillo, A.
  3. Romero-Lorca, A.
  4. Malón, D.
  5. Antón, B.
  6. Moreno, A.
  7. Fernández-Santander, A.
Aldizkaria:
Pharmaceutics

ISSN: 1999-4923

Argitalpen urtea: 2022

Alea: 14

Zenbakia: 2

Mota: Artikulua

DOI: 10.3390/PHARMACEUTICS14020242 GOOGLE SCHOLAR lock_openSarbide irekia editor